-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Elite Pharmaceuticals Inc /Nv/ Operating Income (Loss) for the quarter ending December 31, 2024 was $1.1M, a 68.9% decline year-over-year.
- Elite Pharmaceuticals Inc /Nv/ Operating Income (Loss) for the twelve months ending December 31, 2024 was $12.2M, a 82.5% increase year-over-year.
- Elite Pharmaceuticals Inc /Nv/ annual Operating Income (Loss) for 2023 was $10.8M, a 193% increase from 2022.
- Elite Pharmaceuticals Inc /Nv/ annual Operating Income (Loss) for 2022 was $3.68M, a 27.5% decline from 2021.
- Elite Pharmaceuticals Inc /Nv/ annual Operating Income (Loss) for 2021 was $5.07M, a 141% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)